Index -
P/E 30.24
EPS (ttm) 18.57
Insider Own 2.25%
Shs Outstand 15.03M
Perf Week 0.22%
Market Cap 8.50B
Forward P/E 22.12
EPS next Y 25.39
Insider Trans -9.44%
Shs Float 14.80M
Perf Month -10.75%
Income 283.40M
PEG 2.69
EPS next Q 5.59
Inst Own 95.79%
Short Float 2.95%
Perf Quarter -6.56%
Sales 2.29B
P/S 3.71
EPS this Y 14.83%
Inst Trans 1.15%
Short Ratio 5.20
Perf Half Y -2.49%
Book/sh 78.46
P/B 7.16
EPS next Y 8.92%
ROA 17.94%
Short Interest 0.44M
Perf Year 2.05%
Cash/sh 20.70
P/C 27.14
EPS next 5Y 11.25%
ROE 27.47%
52W Range 492.84 - 654.62
Perf YTD -3.95%
Dividend Est. 1.64 (0.29%)
P/FCF 28.12
EPS past 5Y 7.95%
ROI 21.96%
52W High -14.20%
Beta 0.47
Dividend TTM 1.58 (0.28%)
Quick Ratio 1.88
Sales past 5Y 4.95%
Gross Margin 32.77%
52W Low 13.96%
ATR (14) 11.95
Dividend Ex-Date Feb 23, 2024
Current Ratio 1.91
EPS Y/Y TTM 17.00%
Oper. Margin 14.83%
RSI (14) 28.72
Volatility 1.53% 1.77%
Employees 15087
Debt/Eq 0.13
Sales Y/Y TTM 5.96%
Profit Margin 12.36%
Recom 1.25
Target Price 689.88
Option/Short Yes / Yes
LT Debt/Eq 0.09
EPS Q/Q 18.34%
Payout 8.70%
Rel Volume 0.84
Prev Close 559.65
Sales Surprise -0.38%
EPS Surprise -5.11%
Sales Q/Q 5.19%
Earnings Apr 24 AMC
Avg Volume 83.97K
Price 561.65
SMA20 -6.37%
SMA50 -9.50%
SMA200 -1.21%
Trades
Volume 70,750
Change 0.36%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-20 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$448 → $535
Nov-01-19 Upgrade
JMP Securities
Mkt Perform → Mkt Outperform
$490
Sep-06-19 Reiterated
BofA/Merrill
Buy
$470 → $500
Oct-12-18 Initiated
BofA/Merrill
Buy
$390
Aug-28-17 Initiated
KeyBanc Capital Mkts
Sector Weight
Nov-01-16 Reiterated
RBC Capital Mkts
Sector Perform
$162 → $148
Jul-27-16 Reiterated
RBC Capital Mkts
Sector Perform
$136 → $162
May-02-16 Reiterated
RBC Capital Mkts
Sector Perform
$135 → $136
Oct-26-15 Reiterated
RBC Capital Mkts
Sector Perform
$129 → $154
Oct-26-15 Reiterated
Oppenheimer
Outperform
$150 → $152
Sep-22-15 Reiterated
Oppenheimer
Outperform
$147 → $150
Jul-27-15 Reiterated
RBC Capital Mkts
Sector Perform
$110 → $129
Feb-19-15 Reiterated
Oppenheimer
Outperform
$122 → $123
Sep-23-14 Reiterated
Oppenheimer
Outperform
$110 → $115
Jun-10-14 Reiterated
RBC Capital Mkts
Sector Perform
$70 → $74
May-01-14 Reiterated
Oppenheimer
Outperform
$90 → $92
Sep-10-13 Reiterated
Deutsche Bank
Hold
$70 → $63
Mar-04-11 Reiterated
Barclays Capital
Underweight
$65 → $9
Feb-17-11 Reiterated
RBC Capital Mkts
Sector Perform
$53 → $67
Feb-17-11 Reiterated
Oppenheimer
Outperform
$67 → $72
Show Previous Ratings
Apr-30-24 12:15PM
Apr-26-24 12:35PM
03:17AM
Apr-25-24 11:37PM
(Thomson Reuters StreetEvents) -7.22%
08:27AM
06:10PM
Loading…
Apr-24-24 06:10PM
05:35PM
05:14PM
05:05PM
(Associated Press Finance)
04:15PM
Apr-17-24 10:26AM
10:00AM
Apr-03-24 04:29AM
Apr-01-24 03:00PM
12:00PM
11:30AM
Loading…
Mar-28-24 11:30AM
Mar-22-24 03:00PM
Mar-18-24 09:45AM
Mar-14-24 09:00AM
Mar-13-24 09:00AM
Mar-08-24 12:00PM
Mar-04-24 12:45PM
Feb-29-24 09:03AM
06:37AM
12:15AM
(Thomson Reuters StreetEvents)
Feb-27-24 08:00PM
07:15PM
06:20PM
(Associated Press Finance)
04:53PM
04:15PM
12:27PM
Loading…
Feb-16-24 12:27PM
Feb-14-24 12:00PM
Feb-05-24 10:59AM
Jan-22-24 08:29AM
Jan-08-24 11:24AM
Dec-29-23 12:00PM
Dec-25-23 07:14AM
Dec-22-23 04:18PM
Dec-18-23 01:20PM
Dec-14-23 09:05PM
Nov-30-23 03:00PM
Nov-28-23 05:04AM
Nov-24-23 11:31AM
Nov-17-23 09:55AM
Nov-15-23 10:10PM
Nov-13-23 07:33PM
Nov-08-23 10:33AM
Nov-06-23 09:00AM
Nov-03-23 04:15PM
11:28AM
05:03AM
Nov-02-23 01:03AM
Oct-27-23 03:04PM
08:08AM
12:31AM
(Thomson Reuters StreetEvents)
Oct-25-23 09:30PM
06:50PM
06:26PM
05:47PM
(Associated Press Finance)
04:15PM
Oct-20-23 11:40AM
Oct-11-23 12:00PM
Oct-04-23 11:40AM
Sep-25-23 07:25AM
Sep-18-23 11:40AM
Sep-14-23 10:48AM
Aug-31-23 11:40AM
Aug-15-23 01:20PM
Aug-08-23 06:28AM
Aug-07-23 07:08AM
Aug-04-23 11:56AM
Jul-27-23 08:23AM
Jul-26-23 10:00PM
06:45PM
05:43PM
04:15PM
Jul-21-23 09:56AM
Jul-20-23 11:40AM
Jul-12-23 12:00PM
Jul-10-23 08:25AM
Jun-21-23 08:00PM
Jun-14-23 09:53AM
Jun-06-23 08:40AM
Jun-05-23 08:56AM
Jun-01-23 12:00PM
May-24-23 09:03AM
May-15-23 02:43PM
May-10-23 12:00PM
11:40AM
May-09-23 06:40AM
May-03-23 12:00PM
May-02-23 03:14PM
06:39AM
Apr-30-23 09:13AM
Apr-28-23 11:24AM
Apr-27-23 11:47AM
10:45AM
09:33AM
06:11AM
Apr-26-23 08:00PM
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LEE SPENCER S executive vice president Mar 28 '24 Option Exercise 106.59 13,000 1,385,670 33,760 Apr 01 11:43 AM LEE SPENCER S executive vice president Mar 28 '24 Sale 641.65 2,000 1,283,300 20,760 Apr 01 11:43 AM Witzeman Michael D VP & Chief Financial Officer Mar 21 '24 Sale 643.14 2,650 1,704,321 2,882 Mar 22 01:21 PM Judkins Brian C VP and Chief Legal Officer Mar 20 '24 Option Exercise 443.22 11,958 5,300,013 12,580 Mar 22 11:26 AM Witzeman Michael D VP & Chief Financial Officer Mar 20 '24 Option Exercise 413.19 2,600 1,074,294 5,887 Mar 22 01:21 PM Judkins Brian C VP and Chief Legal Officer Mar 20 '24 Sale 645.00 11,158 7,196,910 1,422 Mar 22 11:26 AM HUTTON THOMAS C vice president Mar 06 '24 Option Exercise 449.03 3,267 1,466,992 39,592 Mar 07 12:59 PM MCNAMARA KEVIN J president and CEO Feb 16 '24 Option Exercise 586.49 2,704 1,585,869 114,172 Feb 20 11:28 AM Westfall Nicholas Michael Executive Vice President Feb 16 '24 Option Exercise 586.49 785 460,395 8,461 Feb 20 03:12 PM LEE SPENCER S executive vice president Feb 16 '24 Option Exercise 586.49 480 281,515 23,048 Feb 20 03:15 PM Witzeman Michael D VP & Chief Financial Officer Feb 16 '24 Option Exercise 586.49 433 253,950 3,417 Feb 20 03:09 PM Judkins Brian C VP and Chief Legal Officer Feb 16 '24 Option Exercise 586.49 368 215,828 843 Feb 20 03:22 PM HUTTON THOMAS C vice president Feb 16 '24 Option Exercise 586.49 210 123,163 36,402 Feb 20 03:49 PM MCNAMARA KEVIN J president and CEO Dec 11 '23 Sale 572.77 1,500 859,155 111,468 Dec 13 11:56 AM LEE SPENCER S executive vice president Nov 27 '23 Sale 579.73 1,000 579,730 22,568 Nov 27 12:33 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 14 '23 Sale 586.08 1,186 695,091 5,826 Nov 15 11:27 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 13 '23 Sale 586.32 3,814 2,236,224 7,012 Nov 15 11:27 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 10 '23 Sale 580.79 5,000 2,903,950 10,826 Nov 13 12:25 PM Witzeman Michael D vice president and controller Nov 08 '23 Option Exercise 413.19 3,300 1,363,527 5,669 Nov 08 02:43 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 07 '23 Sale 583.85 6,000 3,503,100 15,826 Nov 08 11:26 AM LEE SPENCER S executive vice president Nov 07 '23 Sale 583.85 1,217 710,545 23,633 Nov 08 11:29 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 03 '23 Option Exercise 460.80 35,235 16,236,196 52,967 Nov 06 01:28 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 01 '23 Sale 568.87 5,000 2,844,350 17,732 Nov 02 03:45 PM MCNAMARA KEVIN J president and CEO Oct 31 '23 Option Exercise 433.67 15,700 6,808,683 131,615 Nov 01 03:37 PM WILLIAMS DAVID PATRICK executive vice president & CFO Oct 31 '23 Option Exercise 413.19 15,100 6,239,169 22,732 Nov 02 03:45 PM MCNAMARA KEVIN J president and CEO Oct 31 '23 Sale 560.68 5,000 2,803,400 112,968 Nov 01 03:37 PM MCNAMARA KEVIN J president and CEO Aug 04 '23 Option Exercise 413.19 3,000 1,239,570 118,571 Aug 07 10:28 AM MCNAMARA KEVIN J president and CEO Aug 03 '23 Sale 516.43 4,000 2,065,720 115,571 Aug 07 10:28 AM Westfall Nicholas Michael Executive Vice President Jun 01 '23 Option Exercise 413.19 12,670 5,235,117 20,346 Jun 05 03:10 PM Westfall Nicholas Michael Executive Vice President Jun 01 '23 Option Exercise 413.19 1,330 549,543 7,676 Jun 01 02:36 PM Westfall Nicholas Michael Executive Vice President Jun 01 '23 Sale 533.70 12,670 6,761,979 7,676 Jun 05 03:10 PM Westfall Nicholas Michael Executive Vice President May 30 '23 Sale 540.34 1,330 718,652 6,346 Jun 01 02:36 PM GRACE PATRICK P Director May 26 '23 Sale 544.24 294 160,007 3,270 May 30 01:52 PM MCNAMARA KEVIN J president and CEO May 05 '23 Sale 549.34 4,000 2,197,360 119,571 May 08 01:02 PM
Index RUT
P/E -
EPS (ttm) -0.71
Insider Own 29.17%
Shs Outstand 190.73M
Perf Week 5.91%
Market Cap 448.25M
Forward P/E -
EPS next Y -0.02
Insider Trans 0.00%
Shs Float 136.27M
Perf Month -5.67%
Income -134.52M
PEG -
EPS next Q -0.05
Inst Own 20.23%
Short Float 0.76%
Perf Quarter -7.91%
Sales 1.90B
P/S 0.24
EPS this Y 23.86%
Inst Trans -0.02%
Short Ratio 11.17
Perf Half Y 62.94%
Book/sh -0.68
P/B -
EPS next Y 77.19%
ROA -7.90%
Short Interest 1.04M
Perf Year 104.39%
Cash/sh 0.23
P/C 10.20
EPS next 5Y 6.23%
ROE -567.05%
52W Range 0.85 - 3.00
Perf YTD -13.06%
Dividend Est. -
P/FCF 27.07
EPS past 5Y -22.80%
ROI -11.34%
52W High -22.33%
Beta 2.03
Dividend TTM -
Quick Ratio 0.89
Sales past 5Y 8.64%
Gross Margin 30.69%
52W Low 174.12%
ATR (14) 0.15
Dividend Ex-Date -
Current Ratio 0.89
EPS Y/Y TTM 80.12%
Oper. Margin 6.30%
RSI (14) 50.95
Volatility 5.40% 6.43%
Employees 33500
Debt/Eq -
Sales Y/Y TTM 6.02%
Profit Margin -7.10%
Recom 3.25
Target Price 2.57
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 89.45%
Payout -
Rel Volume 0.77
Prev Close 2.27
Sales Surprise 2.98%
EPS Surprise 19.68%
Sales Q/Q 6.14%
Earnings May 09 BMO
Avg Volume 93.25K
Price 2.33
SMA20 0.87%
SMA50 -1.56%
SMA200 15.38%
Trades
Volume 71,988
Change 2.64%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-13-23 Downgrade
JP Morgan
Neutral → Underweight
Nov-30-23 Initiated
UBS
Sell
$1.50
May-12-23 Downgrade
Raymond James
Strong Buy → Mkt Perform
Jan-27-23 Downgrade
Credit Suisse
Neutral → Underperform
$2 → $1
Nov-21-22 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$7 → $3
Nov-17-22 Downgrade
Credit Suisse
Outperform → Neutral
$5.50 → $2
Jul-22-22 Downgrade
Jefferies
Buy → Hold
$2.50
Jul-05-22 Downgrade
Truist
Buy → Hold
Jun-21-22 Downgrade
Stephens
Overweight → Equal-Weight
$5.50 → $3.50
Jun-21-22 Downgrade
BofA Securities
Neutral → Underperform
$3 → $2
Mar-29-22 Downgrade
BofA Securities
Buy → Neutral
$10 → $5.50
May-24-21 Initiated
Truist
Buy
$15
May-24-21 Initiated
RBC Capital Mkts
Outperform
$16
May-24-21 Initiated
Raymond James
Strong Buy
$15
May-24-21 Initiated
JP Morgan
Neutral
$14
May-24-21 Initiated
Jefferies
Buy
$15
May-24-21 Initiated
Deutsche Bank
Buy
$13.50
May-24-21 Initiated
Credit Suisse
Outperform
$16
May-24-21 Initiated
BMO Capital Markets
Outperform
$17
May-24-21 Initiated
Barclays
Overweight
$20
Show Previous Ratings
May-03-24 06:30AM
May-01-24 06:30AM
Apr-18-24 06:30AM
Apr-03-24 06:30AM
Mar-16-24 02:58PM
12:12AM
Loading…
Mar-15-24 12:12AM
(Thomson Reuters StreetEvents)
Mar-14-24 09:30AM
07:55AM
07:51AM
07:09AM
(Associated Press Finance)
06:30AM
Feb-22-24 06:30AM
Dec-11-23 07:30AM
Nov-14-23 09:40AM
Nov-11-23 09:38AM
03:32AM
Loading…
Nov-10-23 03:32AM
(Thomson Reuters StreetEvents) +5.26%
Nov-09-23 09:30AM
07:04AM
06:47AM
(Associated Press Finance)
06:00AM
Nov-08-23 09:33AM
Oct-25-23 09:01AM
Oct-19-23 06:30AM
Aug-12-23 08:23AM
Aug-11-23 04:03AM
(Thomson Reuters StreetEvents)
Aug-10-23 09:30AM
07:50AM
06:45AM
(Associated Press Finance)
06:30AM
Aug-04-23 08:00AM
06:00AM
Loading…
Jul-20-23 06:00AM
Jul-17-23 08:48AM
Jun-15-23 07:00AM
May-22-23 06:44AM
May-17-23 08:30AM
May-12-23 12:28AM
(Thomson Reuters StreetEvents)
May-11-23 07:25AM
06:20AM
06:00AM
May-04-23 10:00AM
Apr-24-23 06:00AM
Apr-08-23 10:28AM
Mar-18-23 02:03AM
Mar-17-23 05:49AM
(Thomson Reuters StreetEvents) -6.47%
Mar-16-23 09:35AM
08:00AM
Feb-27-23 04:05PM
Feb-05-23 08:14AM
Jan-05-23 06:29AM
Jan-04-23 07:35AM
Dec-18-22 11:53AM
Dec-15-22 11:12AM
(American City Business Journals) -6.29%
Dec-13-22 05:07PM
Dec-08-22 07:18AM
Nov-11-22 05:30AM
Nov-09-22 05:45PM
04:05PM
Oct-30-22 10:08AM
Oct-25-22 04:05PM
Oct-06-22 06:57AM
Aug-31-22 04:55PM
Aug-12-22 07:30AM
Aug-10-22 08:25PM
07:12PM
Aug-03-22 10:00AM
Jul-25-22 02:31PM
08:44AM
Jul-24-22 10:33AM
Jul-19-22 09:00AM
Jul-08-22 08:13AM
Jun-27-22 06:18AM
Jun-15-22 06:30AM
May-23-22 07:57AM
May-12-22 06:30PM
May-11-22 05:45PM
04:05PM
08:59AM
May-10-22 08:00AM
Apr-29-22 06:44AM
Apr-21-22 08:00AM
Apr-11-22 11:34AM
Mar-31-22 06:49PM
Mar-29-22 06:30PM
12:26PM
Mar-28-22 04:15PM
Mar-01-22 04:09PM
04:06PM
Feb-14-22 05:12AM
Jan-13-22 05:38PM
Dec-27-21 04:05PM
Dec-19-21 05:38AM
Dec-13-21 08:00AM
Dec-01-21 08:30AM
Nov-19-21 08:00AM
Nov-17-21 10:11AM
12:00AM
Nov-15-21 04:05PM
Oct-29-21 09:46AM
Oct-27-21 08:00AM
Oct-20-21 11:40AM
Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. It operates through the following business segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing services. The HHH segment provides home health, hospice, and program services to predominately elderly populations. The MS segment offers supplies to patients requiring enteral nutrition services or respiratory care. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GANZI VICTOR F Director Jun 06 '23 Buy 1.23 200 246 236,617 Jun 08 09:50 PM GANZI VICTOR F Director Jun 01 '23 Buy 1.18 3,200 3,776 236,417 Jun 01 08:55 PM GANZI VICTOR F Director May 31 '23 Buy 1.15 11,850 13,616 233,217 Jun 01 08:55 PM GANZI VICTOR F Director May 30 '23 Buy 1.14 1,758 2,008 221,367 Jun 01 08:55 PM
Index RUT
P/E -
EPS (ttm) -1.62
Insider Own 12.24%
Shs Outstand 50.05M
Perf Week 1.50%
Market Cap 510.63M
Forward P/E 30.96
EPS next Y 0.33
Insider Trans -0.01%
Shs Float 44.02M
Perf Month -5.83%
Income -80.50M
PEG -
EPS next Q 0.05
Inst Own 105.15%
Short Float 7.02%
Perf Quarter -0.29%
Sales 1.05B
P/S 0.49
EPS this Y 16.10%
Inst Trans -
Short Ratio 5.40
Perf Half Y 39.84%
Book/sh 13.38
P/B 0.76
EPS next Y 28.74%
ROA -5.34%
Short Interest 3.09M
Perf Year -17.10%
Cash/sh 0.59
P/C 17.14
EPS next 5Y -
ROE -11.41%
52W Range 7.12 - 14.59
Perf YTD -1.64%
Dividend Est. -
P/FCF 12.25
EPS past 5Y -
ROI -6.46%
52W High -30.23%
Beta 1.46
Dividend TTM -
Quick Ratio 1.53
Sales past 5Y -1.04%
Gross Margin 45.86%
52W Low 42.98%
ATR (14) 0.38
Dividend Ex-Date -
Current Ratio 1.53
EPS Y/Y TTM -121.76%
Oper. Margin 3.65%
RSI (14) 46.81
Volatility 3.16% 3.22%
Employees 10800
Debt/Eq 0.91
Sales Y/Y TTM -3.40%
Profit Margin -7.69%
Recom 3.12
Target Price 10.93
Option/Short Yes / Yes
LT Debt/Eq 0.86
EPS Q/Q -183.28%
Payout -
Rel Volume 0.49
Prev Close 9.99
Sales Surprise 0.17%
EPS Surprise 138.10%
Sales Q/Q -5.27%
Earnings May 08 AMC
Avg Volume 572.57K
Price 10.18
SMA20 -1.99%
SMA50 -1.15%
SMA200 -3.82%
Trades
Volume 281,688
Change 1.90%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-07-24 Upgrade
UBS
Sell → Neutral
$9.50
Dec-12-23 Initiated
TD Cowen
Market Perform
$12
Jun-20-23 Initiated
SVB Securities
Underperform
$10
Mar-16-23 Initiated
Goldman
Neutral
$15
Dec-13-22 Initiated
CJS Securities
Market Perform
$18
Dec-08-22 Initiated
UBS
Sell
$12
Dec-06-22 Initiated
Stifel
Buy
$17
Oct-14-22 Initiated
Oppenheimer
Perform
Aug-30-22 Initiated
Jefferies
Buy
$20
Aug-25-22 Initiated
Credit Suisse
Neutral
$19
Aug-18-22 Initiated
Citigroup
Neutral
$17
Show Previous Ratings
Apr-10-24 04:10PM
Mar-20-24 05:45PM
Mar-10-24 08:38AM
Mar-07-24 01:39PM
Mar-06-24 09:52PM
04:51PM
Loading…
04:51PM
(Associated Press Finance)
04:15PM
Feb-08-24 04:10PM
Dec-17-23 05:05AM
Nov-12-23 08:57AM
Nov-09-23 01:24AM
(Thomson Reuters StreetEvents)
Nov-07-23 07:15PM
06:10PM
(Associated Press Finance)
04:11PM
Nov-02-23 10:00AM
10:01AM
Loading…
Oct-31-23 10:01AM
Oct-25-23 06:30PM
Oct-05-23 10:00AM
Oct-04-23 04:41PM
Oct-03-23 05:47PM
Aug-23-23 04:51PM
Aug-14-23 09:00AM
Aug-12-23 09:27AM
Aug-11-23 12:12AM
(Thomson Reuters StreetEvents)
Aug-09-23 06:40PM
05:36PM
04:30PM
Aug-08-23 07:50AM
Jul-27-23 11:00AM
Jul-20-23 08:33AM
08:00PM
Loading…
Jun-21-23 08:00PM
Jun-13-23 09:00AM
Jun-01-23 04:10PM
May-10-23 11:58PM
(Thomson Reuters StreetEvents) -8.73%
May-09-23 06:34PM
04:10PM
Apr-26-23 08:00PM
11:35AM
Apr-20-23 07:00AM
Apr-19-23 08:58AM
Apr-13-23 08:00AM
Apr-04-23 01:19PM
Mar-30-23 08:46AM
Mar-27-23 08:56AM
Mar-02-23 07:51AM
Feb-23-23 07:00AM
Feb-16-23 06:29PM
Feb-14-23 07:03PM
Jan-24-23 07:00AM
Jan-19-23 11:06AM
Jan-11-23 05:15AM
Dec-27-22 10:00AM
Dec-12-22 04:20PM
Dec-07-22 08:05AM
Dec-01-22 09:07PM
Nov-29-22 10:00AM
Nov-26-22 08:04PM
Nov-14-22 02:00PM
Nov-10-22 06:47AM
Nov-08-22 05:25AM
Nov-03-22 02:00PM
Nov-01-22 05:40PM
Oct-27-22 07:23AM
Oct-05-22 08:30AM
Oct-03-22 04:20PM
Sep-23-22 07:45AM
Aug-23-22 08:30AM
Aug-01-22 04:20PM
Jul-07-22 08:00AM
Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Langham Ronald Leroy JR EVP Clinical Excel. & Strategy Mar 01 '24 Sale 8.81 634 5,586 57,164 Mar 05 05:48 PM Bolton Jeffrey Director May 26 '23 Buy 11.61 2,000 23,220 19,597 May 31 08:17 PM SHAW L EDWARD JR Director May 22 '23 Buy 11.98 10,000 119,800 38,989 May 23 05:50 PM Langham Ronald Leroy JR EVP Clinical Excel. & Strategy May 18 '23 Buy 11.99 10,000 119,900 44,328 May 22 09:48 AM Hoeflinger Erin Director May 18 '23 Buy 11.82 2,100 24,822 15,697 May 22 10:15 AM Bolton Jeffrey Director May 17 '23 Buy 11.80 2,000 23,600 17,597 May 18 03:01 PM
Index RUT
P/E 25.59
EPS (ttm) 3.84
Insider Own 2.08%
Shs Outstand 16.23M
Perf Week 3.87%
Market Cap 1.61B
Forward P/E 18.39
EPS next Y 5.34
Insider Trans -10.22%
Shs Float 16.03M
Perf Month -3.88%
Income 62.52M
PEG 1.71
EPS next Q 1.11
Inst Own 94.18%
Short Float 2.20%
Perf Quarter 10.49%
Sales 1.06B
P/S 1.52
EPS this Y 6.17%
Inst Trans 2.50%
Short Ratio 2.58
Perf Half Y 21.49%
Book/sh 43.55
P/B 2.25
EPS next Y 9.82%
ROA 6.37%
Short Interest 0.35M
Perf Year 17.59%
Cash/sh 3.96
P/C 24.81
EPS next 5Y 15.00%
ROE 9.33%
52W Range 77.30 - 104.61
Perf YTD 5.76%
Dividend Est. -
P/FCF 15.64
EPS past 5Y 23.63%
ROI 7.18%
52W High -6.13%
Beta 0.99
Dividend TTM -
Quick Ratio 1.38
Sales past 5Y 15.56%
Gross Margin 31.09%
52W Low 27.04%
ATR (14) 3.07
Dividend Ex-Date -
Current Ratio 1.38
EPS Y/Y TTM 34.76%
Oper. Margin 9.21%
RSI (14) 52.89
Volatility 3.02% 3.21%
Employees 34846
Debt/Eq 0.25
Sales Y/Y TTM 11.31%
Profit Margin 5.91%
Recom 1.56
Target Price 109.12
Option/Short Yes / Yes
LT Debt/Eq 0.23
EPS Q/Q 32.22%
Payout 0.00%
Rel Volume 0.86
Prev Close 98.41
Sales Surprise 0.69%
EPS Surprise 12.60%
Sales Q/Q 11.86%
Earnings May 06 AMC
Avg Volume 136.55K
Price 98.20
SMA20 1.34%
SMA50 0.39%
SMA200 8.14%
Trades
Volume 117,674
Change -0.21%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-23-24 Downgrade
Barclays
Equal Weight → Underweight
$83
Mar-06-24 Initiated
Barclays
Equal Weight
$88
Feb-05-24 Resumed
William Blair
Outperform
Dec-12-23 Initiated
TD Cowen
Outperform
$105
Jun-29-22 Initiated
Stifel
Buy
$101
Apr-13-22 Initiated
BofA Securities
Buy
$110
Oct-22-19 Resumed
Stephens
Overweight
Jun-27-19 Initiated
BMO Capital Markets
Market Perform
Feb-04-19 Upgrade
Robert W. Baird
Neutral → Outperform
Oct-08-18 Initiated
RBC Capital Mkts
Outperform
$81
Aug-21-18 Initiated
Jefferies
Buy
$75
Aug-20-18 Initiated
Raymond James
Outperform
$75
Sep-30-14 Upgrade
Oppenheimer
Perform → Outperform
$24
Jul-16-13 Downgrade
Robert W. Baird
Outperform → Neutral
$14 → $20
Apr-04-13 Downgrade
Oppenheimer
Outperform → Perform
$12 → $13
Dec-07-09 Initiated
Robert W. Baird
Outperform
$13
Dec-07-09 Initiated
Oppenheimer
Outperform
$12
Show Previous Ratings
May-02-24 09:40AM
Apr-23-24 09:18AM
08:00AM
Apr-22-24 11:00AM
Apr-13-24 12:18PM
09:00AM
Loading…
Apr-09-24 09:00AM
Mar-05-24 11:00AM
Mar-04-24 09:15AM
Mar-01-24 08:30AM
Feb-29-24 12:00PM
Feb-27-24 11:00AM
Feb-26-24 06:30PM
04:54PM
(Associated Press Finance)
04:53PM
04:05PM
09:15AM
Loading…
Feb-21-24 09:15AM
Feb-12-24 11:00AM
Nov-22-23 09:55AM
Nov-17-23 05:05AM
Nov-06-23 09:55AM
Nov-01-23 12:37PM
11:00AM
Oct-30-23 05:50PM
05:43PM
04:50PM
(Associated Press Finance)
04:05PM
Oct-23-23 10:15AM
Oct-19-23 11:40AM
Oct-17-23 06:21AM
Oct-16-23 12:00PM
08:58AM
Loading…
08:58AM
Oct-10-23 09:40AM
Oct-03-23 11:40AM
Sep-25-23 03:21AM
Sep-24-23 10:30AM
Aug-02-23 04:05PM
Aug-01-23 08:00AM
Jul-31-23 06:25PM
05:12PM
04:05PM
Jul-29-23 11:30AM
Jul-24-23 10:00AM
Jul-23-23 09:03AM
Jul-20-23 12:10PM
Jul-17-23 01:00PM
Jul-03-23 01:01PM
Jun-29-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 09:53AM
Jun-09-23 01:39PM
Jun-08-23 12:44PM
Jun-07-23 01:53PM
12:52PM
Jun-06-23 10:20AM
Jun-05-23 02:12PM
11:45AM
11:40AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:04PM
May-29-23 09:55AM
May-26-23 10:55AM
May-25-23 02:30PM
09:35AM
May-24-23 01:42PM
11:00AM
May-23-23 11:23AM
11:01AM
May-22-23 11:13AM
10:48AM
May-19-23 11:39AM
10:48AM
May-18-23 01:12PM
01:09PM
11:40AM
10:50AM
May-17-23 02:15PM
May-11-23 09:40AM
May-09-23 11:00AM
09:35AM
May-02-23 11:16PM
(Thomson Reuters StreetEvents)
11:00AM
May-01-23 05:45PM
04:05PM
02:37PM
11:40AM
08:00AM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
09:40AM
07:38AM
Apr-24-23 10:00AM
Apr-17-23 11:00AM
Apr-14-23 11:40AM
Apr-10-23 09:40AM
Mar-29-23 08:00AM
Mar-24-23 09:40AM
07:07AM
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stevenson Roberton James EVP & Chief HR Officer Apr 01 '24 Sale 103.93 109 11,328 10,434 Apr 02 04:05 PM RAINES MONICA EVP/CCO and Quality Officer Mar 04 '24 Sale 93.86 235 22,057 11,986 Mar 05 04:09 PM ALLISON R DIRK CEO and Chairman Feb 26 '24 Sale 85.95 8,021 689,405 79,397 Feb 27 04:10 PM BICKHAM W BRADLEY President and COO Feb 26 '24 Sale 85.95 5,212 447,971 48,000 Feb 27 04:10 PM POFF BRIAN EVP/Chief Financial Officer Feb 26 '24 Sale 85.95 4,814 413,763 31,544 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Feb 26 '24 Sale 85.94 1,763 151,512 40,754 Feb 27 04:10 PM GAFFNEY SEAN EVP/Chief Legal Officer Feb 26 '24 Sale 85.95 1,639 140,872 18,002 Feb 27 04:10 PM TUCKER DAVID W. EVP/Chief Strategy Officer Feb 26 '24 Sale 85.96 1,347 115,788 10,497 Feb 27 04:10 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Feb 26 '24 Sale 85.95 1,176 101,077 9,132 Feb 27 04:10 PM Stevenson Roberton James EVP & Chief HR Officer Feb 26 '24 Sale 85.95 714 61,368 10,543 Feb 27 04:10 PM RAINES MONICA EVP/CCO and Quality Officer Feb 26 '24 Sale 85.96 538 46,246 12,221 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Option Exercise 23.10 9,690 223,839 46,550 Nov 16 04:39 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Sale 85.00 9,690 823,650 36,860 Nov 16 04:39 PM TUCKER DAVID W. EVP / Chief Strategy Officer Nov 08 '23 Sale 83.45 248 20,696 6,973 Nov 09 05:13 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Nov 08 '23 Sale 83.45 235 19,611 5,987 Nov 09 05:14 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Option Exercise 23.10 3,008 69,485 39,868 Nov 09 05:13 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Sale 85.00 3,008 255,680 36,860 Nov 09 05:13 PM BICKHAM W BRADLEY President and COO Aug 07 '23 Sale 93.85 5,000 469,250 38,285 Aug 08 05:01 PM TUCKER DAVID W. EVP / Chief Strategy Officer Aug 07 '23 Sale 94.23 1,636 154,160 7,221 Aug 08 05:01 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Aug 07 '23 Sale 93.96 750 70,470 6,222 Aug 08 05:02 PM POFF BRIAN EVP/Chief Financial Officer Aug 04 '23 Sale 93.55 4,140 387,316 22,217 Aug 04 05:30 PM ALLISON R DIRK CEO and Chairman Aug 03 '23 Sale 94.39 24,922 2,352,473 52,850 Aug 04 05:29 PM Stevenson Roberton James EVP & Chief HR Officer Jun 15 '23 Sale 92.61 217 20,096 7,329 Jun 20 05:02 PM
Index RUT
P/E 19.61
EPS (ttm) 1.52
Insider Own 0.79%
Shs Outstand 174.58M
Perf Week 0.68%
Market Cap 5.18B
Forward P/E 21.81
EPS next Y 1.37
Insider Trans 2.46%
Shs Float 172.45M
Perf Month -5.87%
Income 272.67M
PEG 1.96
EPS next Q 0.28
Inst Own 98.36%
Short Float 2.50%
Perf Quarter -5.49%
Sales 4.43B
P/S 1.17
EPS this Y -19.96%
Inst Trans 3.09%
Short Ratio 3.29
Perf Half Y 3.98%
Book/sh 8.22
P/B 3.63
EPS next Y 15.39%
ROA 8.55%
Short Interest 4.30M
Perf Year -9.09%
Cash/sh 1.26
P/C 23.61
EPS next 5Y 10.00%
ROE 19.62%
52W Range 24.23 - 35.74
Perf YTD -11.52%
Dividend Est. -
P/FCF 30.33
EPS past 5Y -
ROI 10.59%
52W High -16.59%
Beta 1.33
Dividend TTM -
Quick Ratio 1.39
Sales past 5Y 17.51%
Gross Margin 21.01%
52W Low 23.03%
ATR (14) 1.02
Dividend Ex-Date -
Current Ratio 1.77
EPS Y/Y TTM 74.47%
Oper. Margin 7.15%
RSI (14) 40.98
Volatility 3.51% 3.43%
Employees 5809
Debt/Eq 0.82
Sales Y/Y TTM 9.59%
Profit Margin 6.15%
Recom 1.11
Target Price 39.45
Option/Short Yes / Yes
LT Debt/Eq 0.80
EPS Q/Q 18.83%
Payout 0.00%
Rel Volume 1.58
Prev Close 29.89
Sales Surprise 4.03%
EPS Surprise 15.15%
Sales Q/Q 12.82%
Earnings Apr 23 BMO
Avg Volume 1.31M
Price 29.81
SMA20 -2.74%
SMA50 -5.88%
SMA200 -7.21%
Trades
Volume 2,075,681
Change -0.27%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-27-23 Resumed
Jefferies
Buy
$38
Jul-19-21 Upgrade
Goldman
Neutral → Buy
$20 → $25
Jan-22-21 Initiated
Deutsche Bank
Buy
$22
Jan-11-21 Initiated
JP Morgan
Overweight
$21
Dec-15-20 Initiated
Goldman
Neutral
$18
Jun-24-20 Initiated
BofA/Merrill
Buy
$18
Apr-29-24 04:05PM
Apr-26-24 12:00PM
09:40AM
Apr-25-24 11:27AM
Apr-24-24 03:49AM
(Thomson Reuters StreetEvents)
03:03AM
Loading…
03:03AM
Apr-23-24 11:54AM
08:33AM
08:19AM
08:15AM
07:15AM
(Associated Press Finance)
07:00AM
Apr-22-24 12:10PM
Apr-16-24 10:00AM
Apr-04-24 04:05PM
05:25PM
Loading…
Mar-26-24 05:25PM
Mar-14-24 07:14PM
05:04PM
04:58PM
04:25PM
Mar-07-24 10:07AM
Feb-23-24 12:34PM
Feb-22-24 11:53PM
(Thomson Reuters StreetEvents)
08:20AM
07:31AM
07:24AM
(Associated Press Finance)
07:00AM
Feb-02-24 06:10AM
Jan-22-24 04:05PM
Jan-08-24 07:00AM
05:14AM
Loading…
Dec-19-23 05:14AM
Dec-11-23 04:05PM
Dec-06-23 04:11PM
Nov-07-23 04:05PM
Oct-26-23 09:35AM
Oct-25-23 10:27PM
(Thomson Reuters StreetEvents) -15.49%
07:05PM
09:56AM
08:15AM
07:08AM
(Associated Press Finance)
07:00AM
Oct-20-23 11:47AM
Oct-18-23 12:04PM
Oct-16-23 02:53PM
Oct-02-23 05:56AM
Sep-29-23 03:59PM
08:19AM
Sep-28-23 08:26PM
Sep-27-23 09:24PM
04:05PM
Sep-15-23 09:18AM
Sep-12-23 08:32AM
Sep-08-23 06:23PM
Sep-05-23 07:54AM
Sep-01-23 11:19AM
Aug-31-23 05:00PM
11:40AM
03:34AM
Aug-28-23 09:59AM
Aug-18-23 07:39AM
Aug-14-23 07:03PM
Aug-11-23 09:39AM
Aug-10-23 12:20PM
10:12AM
Aug-03-23 08:06AM
Aug-02-23 07:53AM
07:37AM
Jul-28-23 12:00PM
Jul-27-23 08:25AM
07:20AM
07:00AM
Jul-25-23 05:36AM
Jul-19-23 11:40AM
Jul-06-23 11:22AM
08:00AM
Jun-30-23 01:04PM
Jun-28-23 09:21AM
Jun-27-23 08:18AM
Jun-26-23 01:39PM
(The Wall Street Journal) +5.18%
09:04AM
08:57AM
08:44AM
Jun-21-23 08:00PM
Jun-11-23 03:45AM
Jun-06-23 01:14PM
08:55AM
Jun-05-23 11:40AM
08:31AM
08:25AM
08:13AM
May-23-23 04:05PM
11:53AM
May-18-23 04:05PM
May-05-23 04:05PM
May-04-23 12:29PM
May-03-23 07:35PM
06:27PM
04:53PM
04:31PM
04:30PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bavaro Michael Chief Human Resources Officer Feb 28 '24 Sale 31.73 1,984 62,944 43,428 Mar 01 04:28 PM KRAEMER HARRY M JANSEN JR Director Feb 26 '24 Buy 31.55 35,000 1,104,352 269,528 Feb 28 04:41 PM RADEMACHER JOHN CHARLES Chief Executive Officer Feb 21 '24 Option Exercise 0.00 11,087 0 705,876 Feb 23 06:21 PM SHAPIRO MICHAEL H. Chief Financial Officer Feb 17 '24 Option Exercise 0.00 3,652 0 180,570 Feb 21 09:55 PM Bierbower Elizabeth D Director Oct 30 '23 Buy 26.37 3,000 79,110 13,515 Nov 01 05:09 PM Pate R Carter Director Aug 17 '23 Buy 34.32 1,465 50,279 106,112 Aug 21 05:08 PM Smyser Collin GC & Corporate Secretary Aug 14 '23 Buy 34.69 2,500 86,725 2,500 Aug 15 05:24 PM KRAEMER HARRY M JANSEN JR Director Aug 11 '23 Buy 34.63 55,000 1,904,518 234,528 Aug 15 05:26 PM Smyser Collin GC & Corporate Secretary May 19 '23 Option Exercise 0.00 812 0 16,623 May 22 04:08 PM
Index -
P/E -
EPS (ttm) -0.65
Insider Own 2.54%
Shs Outstand 32.67M
Perf Week 0.32%
Market Cap 3.01B
Forward P/E 18.72
EPS next Y 4.92
Insider Trans 0.00%
Shs Float 31.85M
Perf Month -0.78%
Income -20.59M
PEG -
EPS next Q 1.25
Inst Own 94.00%
Short Float 7.50%
Perf Quarter -2.74%
Sales 2.25B
P/S 1.34
EPS this Y 6.53%
Inst Trans 3.97%
Short Ratio 8.67
Perf Half Y 0.70%
Book/sh 33.30
P/B 2.76
EPS next Y 7.35%
ROA -1.02%
Short Interest 2.39M
Perf Year 17.11%
Cash/sh 3.69
P/C 24.93
EPS next 5Y 5.89%
ROE -1.90%
52W Range 73.10 - 96.44
Perf YTD -3.13%
Dividend Est. -
P/FCF 30.78
EPS past 5Y -
ROI -1.37%
52W High -4.52%
Beta 0.81
Dividend TTM -
Quick Ratio 1.09
Sales past 5Y 6.29%
Gross Margin 32.20%
52W Low 25.96%
ATR (14) 0.88
Dividend Ex-Date -
Current Ratio 1.09
EPS Y/Y TTM -118.42%
Oper. Margin 8.25%
RSI (14) 52.02
Volatility 0.98% 0.95%
Employees 19000
Debt/Eq 0.44
Sales Y/Y TTM 0.76%
Profit Margin -0.91%
Recom 2.60
Target Price 100.86
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q -43.55%
Payout -
Rel Volume 0.89
Prev Close 92.43
Sales Surprise 1.07%
EPS Surprise 0.97%
Sales Q/Q 2.70%
Earnings Apr 24 AMC
Avg Volume 275.60K
Price 92.08
SMA20 0.44%
SMA50 -0.40%
SMA200 -1.12%
Trades
Volume 246,618
Change -0.38%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-07-23 Downgrade
Truist
Buy → Hold
$97
Apr-21-23 Initiated
Cantor Fitzgerald
Neutral
$87
Mar-13-23 Initiated
Barclays
Equal Weight
$93
Oct-27-22 Downgrade
Raymond James
Outperform → Mkt Perform
Aug-02-22 Downgrade
UBS
Neutral → Sell
$145 → $95
Jun-29-22 Initiated
Stifel
Hold
$128
Jun-21-22 Downgrade
BofA Securities
Neutral → Underperform
$145 → $102
Mar-01-22 Upgrade
UBS
Sell → Neutral
$168
Feb-25-22 Upgrade
BMO Capital Markets
Market Perform → Outperform
$210 → $190
Feb-25-22 Reiterated
Truist
Buy
$210 → $200
Feb-25-22 Reiterated
RBC Capital Mkts
Outperform
$221 → $199
Feb-25-22 Reiterated
Raymond James
Outperform
$225 → $200
Feb-25-22 Reiterated
Oppenheimer
Outperform
$225 → $200
Feb-25-22 Reiterated
Credit Suisse
Outperform
$200 → $195
Sep-27-21 Initiated
SVB Leerink
Mkt Perform
$170
Sep-24-21 Initiated
UBS
Sell
$150
Sep-10-21 Initiated
Cowen
Market Perform
$195
Aug-10-21 Reiterated
The Benchmark Company
Buy
$320 → $235
Aug-05-21 Downgrade
BofA Securities
Buy → Neutral
$220
Aug-20-20 Resumed
Barclays
Overweight
$290
Show Previous Ratings
Apr-29-24 08:19AM
Apr-24-24 10:53PM
09:00PM
06:00PM
04:57PM
(Associated Press Finance)
04:45PM
Loading…
04:45PM
10:01AM
Apr-23-24 09:40AM
Mar-25-24 09:40AM
Mar-22-24 11:30AM
Mar-20-24 08:56AM
Mar-19-24 06:16PM
06:02PM
05:41PM
Feb-23-24 11:31AM
08:00PM
Loading…
Feb-21-24 08:00PM
06:00PM
05:04PM
(Associated Press Finance)
04:57PM
04:30PM
Feb-14-24 10:00AM
Feb-08-24 07:30AM
Nov-29-23 08:31PM
Nov-23-23 11:30AM
Nov-22-23 01:44PM
Oct-26-23 08:19AM
Oct-25-23 10:27PM
(Thomson Reuters StreetEvents)
Oct-24-23 07:30PM
06:02PM
05:50PM
04:40PM
Loading…
04:40PM
(Associated Press Finance)
04:30PM
Oct-18-23 04:30PM
09:40AM
Oct-03-23 04:58PM
Oct-02-23 09:40AM
Aug-31-23 11:31AM
07:30AM
Jul-28-23 11:47AM
Jul-27-23 08:47AM
Jul-26-23 10:00PM
06:05PM
05:00PM
04:30PM
Jul-24-23 10:00AM
Jul-19-23 10:01AM
Jul-06-23 10:06AM
Jun-28-23 09:21AM
Jun-27-23 12:45PM
Jun-26-23 02:06PM
01:39PM
(The Wall Street Journal)
10:15AM
09:34AM
09:10AM
08:58AM
08:57AM
08:44AM
Jun-21-23 08:00PM
Jun-20-23 08:30AM
Jun-16-23 02:03PM
Jun-14-23 09:53AM
Jun-11-23 03:45AM
Jun-06-23 11:10AM
08:40AM
Jun-05-23 11:40AM
08:36AM
08:25AM
08:20AM
08:13AM
May-04-23 12:47PM
12:29PM
May-03-23 09:00PM
05:55PM
04:58PM
04:53PM
04:42PM
04:31PM
04:30PM
Apr-26-23 08:00PM
Apr-20-23 08:00AM
Apr-14-23 10:26AM
Apr-12-23 01:27PM
Apr-04-23 08:43AM
Mar-27-23 02:41PM
Mar-23-23 06:11PM
Mar-13-23 04:20PM
Mar-09-23 09:46AM
07:30AM
Feb-23-23 06:32AM
Feb-17-23 08:15AM
Feb-15-23 05:55PM
04:10PM
04:10PM
04:10PM
Feb-09-23 04:15PM
Feb-08-23 10:00AM
07:00AM
Jan-30-23 08:00AM
Jan-12-23 07:57AM
Jan-11-23 08:16AM
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ashworth Richard M President and CEO Dec 26 '23 Option Exercise 79.82 11,237 896,937 67,653 Dec 28 06:02 PM
Index RUT
P/E -
EPS (ttm) -5.24
Insider Own 46.98%
Shs Outstand 132.63M
Perf Week 3.01%
Market Cap 1.37B
Forward P/E 9.76
EPS next Y 1.05
Insider Trans -0.56%
Shs Float 71.01M
Perf Month -1.72%
Income -681.40M
PEG -
EPS next Q 0.06
Inst Own 58.20%
Short Float 10.24%
Perf Quarter 37.35%
Sales 3.20B
P/S 0.43
EPS this Y -33.77%
Inst Trans 10.48%
Short Ratio 6.23
Perf Half Y 43.30%
Book/sh 11.00
P/B 0.93
EPS next Y 20.42%
ROA -13.66%
Short Interest 7.27M
Perf Year -11.25%
Cash/sh 0.58
P/C 17.82
EPS next 5Y 14.00%
ROE -37.75%
52W Range 6.37 - 15.37
Perf YTD 40.74%
Dividend Est. -
P/FCF 9.60
EPS past 5Y -
ROI -18.61%
52W High -33.25%
Beta 1.09
Dividend TTM -
Quick Ratio 1.00
Sales past 5Y 62.79%
Gross Margin 13.20%
52W Low 61.07%
ATR (14) 0.49
Dividend Ex-Date -
Current Ratio 1.21
EPS Y/Y TTM -1177.51%
Oper. Margin 7.82%
RSI (14) 54.76
Volatility 4.86% 4.80%
Employees 10700
Debt/Eq 1.57
Sales Y/Y TTM 7.73%
Profit Margin -21.29%
Recom 2.00
Target Price 11.85
Option/Short Yes / Yes
LT Debt/Eq 1.51
EPS Q/Q -9815.54%
Payout -
Rel Volume 1.55
Prev Close 10.35
Sales Surprise 3.97%
EPS Surprise 188.68%
Sales Q/Q 9.99%
Earnings May 07 BMO
Avg Volume 1.17M
Price 10.26
SMA20 3.75%
SMA50 0.69%
SMA200 9.69%
Trades
Volume 1,805,061
Change -0.87%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-08-24 Downgrade
Jefferies
Buy → Hold
$14.50 → $8
Nov-08-23 Downgrade
BofA Securities
Neutral → Underperform
$9.50 → $6.50
May-10-23 Downgrade
Stifel
Buy → Hold
$18 → $11
May-10-23 Downgrade
Deutsche Bank
Buy → Hold
$28 → $11.30
May-09-23 Downgrade
BofA Securities
Buy → Neutral
$21 → $12
Sep-27-21 Initiated
SVB Leerink
Outperform
$30
Jul-14-21 Upgrade
Robert W. Baird
Neutral → Outperform
$30 → $36
Apr-13-21 Downgrade
Robert W. Baird
Outperform → Neutral
Mar-18-21 Initiated
Truist
Buy
Jan-26-21 Initiated
BofA Securities
Buy
$46
Dec-10-20 Initiated
UBS
Buy
$49
Aug-10-20 Initiated
Canaccord Genuity
Buy
$31
Jul-01-20 Resumed
SVB Leerink
Outperform
$21
Jun-09-20 Initiated
RBC Capital Mkts
Outperform
$24
Jan-31-20 Initiated
Stifel
Buy
$17
Jan-07-20 Initiated
Jefferies
Buy
$15
Dec-11-19 Initiated
SVB Leerink
Outperform
Dec-10-19 Initiated
Deutsche Bank
Buy
Show Previous Ratings
Apr-24-24 09:40AM
Apr-18-24 08:00AM
Apr-17-24 06:51PM
04:15PM
Apr-08-24 09:40AM
09:40AM
Loading…
Mar-22-24 09:40AM
Mar-08-24 11:59AM
Mar-06-24 09:40AM
Mar-04-24 04:05PM
Mar-01-24 08:00AM
Feb-28-24 10:53AM
Feb-27-24 10:53PM
(Thomson Reuters StreetEvents) +31.06%
11:28AM
07:33AM
07:00AM
04:05PM
Loading…
Feb-08-24 04:05PM
Dec-19-23 05:05PM
Nov-10-23 08:00AM
Nov-08-23 05:11PM
Nov-07-23 11:41PM
(Thomson Reuters StreetEvents) -8.99%
08:11AM
07:00AM
Oct-17-23 04:05PM
Oct-11-23 12:07PM
Sep-20-23 12:47PM
(Associated Press Finance) -6.49%
11:44AM
08:54AM
08:45AM
08:38AM
Sep-14-23 07:37PM
01:31PM
Loading…
01:31PM
Sep-07-23 08:00AM
Aug-17-23 07:17PM
07:31AM
Aug-08-23 10:50AM
06:30AM
Aug-03-23 08:00AM
Aug-02-23 01:24PM
Jul-18-23 08:00AM
Jul-17-23 07:27AM
Jun-28-23 08:12AM
Jun-27-23 08:16AM
Jun-21-23 08:00PM
Jun-20-23 08:40AM
May-19-23 08:32AM
May-15-23 12:28PM
May-11-23 02:00PM
May-09-23 06:18PM
08:55AM
07:35AM
07:35AM
Apr-26-23 08:00PM
Apr-18-23 08:32AM
Apr-17-23 09:10AM
Apr-11-23 04:15PM
Mar-27-23 08:22AM
Mar-02-23 05:44AM
Mar-01-23 05:08AM
01:01AM
(Thomson Reuters StreetEvents)
Feb-28-23 12:00PM
10:55AM
Feb-27-23 07:45PM
05:28PM
Feb-25-23 02:14PM
Feb-21-23 10:00AM
Feb-14-23 07:00AM
Feb-07-23 05:32AM
Jan-11-23 03:13PM
(Investor's Business Daily)
Jan-10-23 07:33PM
11:25AM
Dec-23-22 04:53PM
Dec-21-22 05:15AM
Nov-30-22 12:46PM
10:53AM
Nov-16-22 08:34AM
Nov-10-22 06:23AM
Nov-08-22 12:54PM
08:25AM
07:00AM
Oct-20-22 09:00AM
Oct-18-22 08:08AM
Sep-19-22 08:54AM
Sep-16-22 09:00AM
Sep-13-22 09:55AM
Aug-09-22 02:34PM
02:00PM
08:30AM
(Thomson Reuters StreetEvents)
08:25AM
08:00AM
07:00AM
Aug-08-22 10:06AM
Aug-03-22 03:17PM
(Investor's Business Daily)
07:23AM
Aug-01-22 09:19PM
Jul-22-22 10:42AM
(Investor's Business Daily)
Jul-20-22 11:37AM
(Investor's Business Daily)
Jul-13-22 04:00PM
Jun-25-22 09:26AM
Jun-01-22 03:50PM
May-18-22 12:12PM
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Flynn James E 10% Owner Mar 12 '24 Sale 10.70 114,906 1,229,494 11,528,863 Mar 12 07:01 PM Flynn James E 10% Owner Mar 11 '24 Sale 11.02 182,607 2,012,557 11,643,769 Mar 12 07:01 PM Flynn James E 10% Owner Mar 08 '24 Sale 10.93 52,487 573,652 11,826,376 Mar 12 07:01 PM Williams David Solomon III Director Dec 04 '23 Sale 9.30 2,255 20,972 29,779 Dec 06 05:05 PM SkyKnight Aero Holdings, LLC Director Aug 11 '23 Sale 14.02 137,787 1,931,085 2,815,117 Aug 14 04:23 PM SkyKnight Aero Holdings, LLC Director Aug 11 '23 Sale 14.02 59,052 827,614 5,565,126 Aug 14 04:23 PM Prast Albert A. Chief Technology Officer Aug 10 '23 Option Exercise 2.69 200,000 538,000 310,578 Aug 14 06:59 PM Clemens Jason A Chief Financial Officer Aug 10 '23 Buy 14.10 720 10,152 194,120 Aug 14 06:58 PM Prast Albert A. Chief Technology Officer Aug 10 '23 Sale 14.18 200,000 2,836,179 110,578 Aug 14 06:59 PM SkyKnight Aero Holdings, LLC Director Aug 10 '23 Sale 14.05 90,152 1,266,293 2,952,904 Aug 14 04:23 PM SkyKnight Aero Holdings, LLC Director Aug 10 '23 Sale 14.05 38,636 542,689 5,624,178 Aug 14 04:23 PM GRIGGS STEPHEN P Chief Executive Officer May 08 '23 Option Exercise 4.38 559,071 2,448,731 743,534 May 10 07:13 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite